The main finding of the present study was that patients with CKD stages 3 and 4, without a diagnosis of cerebrovascular disease or dementia, had elevated plasma concentrations of NfL, p-Tau231 and GFAP compared with controls with normal mGFR. This evidence concerns the gene GFAP and cerebrovascular disorder.